カテゴリ： MarketLine, アイルランド, 企業調査

Escher Group Holdings plc：企業の戦略・SWOT・財務情報

◆英語タイトル：Escher Group Holdings plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6969
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：39
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アイルランド
◆産業分野：技術・通信
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Escher Group Holdings plc – Strategy, SWOT and Corporate Finance Report
Summary

Escher Group Holdings plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Escher Group Holdings plc (Escher Group) is a provider of retail and message-based software solutions and services. It develops, markets, sells and supports enterprise-wide software applications for post office counter automation and distributed network communication. It also offers mobile wallet based on near field communication, which permits device-to-device communication facilitating information collection, exchange payment processing and smart postering. It offers RiposteTrEx, a digital mailbox solution, which help businesses, citizens, governments and international agencies to collaborate securely online using mobile devices and through social networking channels. It offers its services to various industries, including postal, logistics, retail, government and finance. The company conducts its business operations across Ireland, the US, Singapore, South Africa and the UK. Escher Group is headquartered in Dublin, Ireland.

Scope

- Detailed information on Escher Group Holdings plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Escher Group Holdings plc in the form of a SWOT analysis
- An in-depth view of the business model of Escher Group Holdings plc including a breakdown and examination of key business segments
- Intelligence on Escher Group Holdings plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Escher Group Holdings plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Escher Group Holdings plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Escher Group Holdings plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Escher Group Holdings plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Escher Group Holdings plc: Company Overview 9
Escher Group Holdings plc: Overview and Key Facts 9
Escher Group Holdings plc: Overview 9
Escher Group Holdings plc: Key Facts 9
Escher Group Holdings plc: Key Employees 11
Escher Group Holdings plc: Key Employee Biographies 12
Escher Group Holdings plc: Major Products and Services 14
Escher Group Holdings plc: Company History 15
Escher Group Holdings plc: Management Statement 16
Escher Group Holdings plc: Locations and Subsidiaries 17
Escher Group Holdings plc: Key Competitors 18
Escher Group Holdings plc: Company Analysis 19
Escher Group Holdings plc: Business Description 19
Escher Group Holdings plc: SWOT Analysis 21
Escher Group Holdings plc: SWOT Overview 21
Escher Group Holdings plc: Strengths 21
Escher Group Holdings plc: Weaknesses 22
Escher Group Holdings plc: Opportunities 22
Escher Group Holdings plc: Threats 23
Escher Group Holdings plc: Corporate Financial Deals Activity 24
Escher Group Holdings plc: Financial Deals Overview 24
Escher Group Holdings plc: Targets and Partners 26
Escher Group Holdings plc: Top Deals 2014 – 2018YTD* 27
Escher Group Holdings plc: Advisors 28
Escher Group Holdings plc: Top Financial Advisors 28
Escher Group Holdings plc: Corporate Venturing 29
Escher Group Holdings plc: Private Equity and Ownership 30
Escher Group Holdings plc: Recent Developments 31
Escher Group Holdings plc: News and Events Summary 31
Escher Group Holdings plc: Contracts 32
Escher Group Holdings plc: Corporate Governance 34
Escher Group Holdings plc: Financial Performance 35
Escher Group Holdings plc: Strategy and Operations 35
Appendix 37
Contact Us 37
Methodology 37
About MarketLine 38

List of Tables
Table 1: Escher Group Holdings plc: Key Facts
Table 2: Escher Group Holdings plc: Key Employees
Table 3: Escher Group Holdings plc: Company History
Table 4: Escher Group Holdings plc: Locations and Subsidiaries
Table 5: Escher Group Holdings plc: Key Competitors
Table 6: Escher Group Holdings plc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Escher Group Holdings plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Escher Group Holdings plc: Targets and Partners
Table 9: Escher Group Holdings plc: Top Deals 2014 - 2018YTD*
Table 10: Escher Group Holdings plc: Financial Advisor Ranking by Value (US$m)
Table 11: Escher Group Holdings plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 12: Escher Group Holdings plc: Corporate Venturing by Geography (2014 - YTD*2018)
Table 13: Escher Group Holdings plc: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 14: Escher Group Holdings plc: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 15: Escher Group Holdings plc: News and Events Summary
Table 16: Escher Group Holdings plc: Contracts
Table 17: Escher Group Holdings plc: Corporate Governance
Table 18: Escher Group Holdings plc: Financial Performance
Table 19: Escher Group Holdings plc: Strategy and Operations

List of Figures
Figure 1: Escher Group Holdings plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Escher Group Holdings plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Escher Group Holdings plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 4: Escher Group Holdings plc: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 5: Escher Group Holdings plc: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Escher Group Holdings plc: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Escher Group Holdings plc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Euro-Diagnostica AB-医療機器分野：企業M&A・提携分析
    Summary Euro-Diagnostica AB (Euro Diagnostica) is a medical device company that manufactures and markets purified reagents and antibodies. The company offers blood based solutions, developed to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune diseases. It offers product …
  • BioRap Technologies Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary BioRap Technologies Ltd (BioRap) is a technology transfer company that offers biomedical solutions for contemporary health care industry. The company’s technologies are used in the treatment of macular disease, alopecia, cardiovascular disease, cancer and autoimmune diseases, cancer therapy, …
  • Whirlpool Of India Limited：企業の戦略・SWOT・財務情報
    Whirlpool Of India Limited - Strategy, SWOT and Corporate Finance Report Summary Whirlpool Of India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ortivus AB (ORTI B)：企業の財務・戦略的SWOT分析
    Summary Ortivus AB (Ortivus) is a supplier of mobile solutions for emergency medical care. The company develops and offers cardiology, and mobile monitoring and communication solutions. Its products include MobiMed Smart, CoroNet, excense heart record system and excense decision support healthcare s …
  • Red Electrica Corporacion, S.A.：企業の戦略・SWOT・財務情報
    Red Electrica Corporacion, S.A. - Strategy, SWOT and Corporate Finance Report Summary Red Electrica Corporacion, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Oblong Inc (OBLG)：企業の財務・戦略的SWOT分析
    Oblong Inc (OBLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • GSE Group：企業の戦略・SWOT・財務情報
    GSE Group - Strategy, SWOT and Corporate Finance Report Summary GSE Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Jadason Enterprises Limited (J03)：企業の財務・戦略的SWOT分析
    Jadason Enterprises Limited (J03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • VentiRx Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary VentiRx Pharmaceuticals Inc (VentiRx) is a biopharmaceutical company that develops and commercializes drugs for the treatment of respiratory, autoimmune diseases and cancer. The company develops toll like receptor 8 agonist and antagonists for the treatment of cancer, respiratory and autoimm …
  • Copenhagen Infrastructure Partners KS：電力：M&Aディール及び事業提携情報
    Summary Copenhagen Infrastructure Partners KS (CIP) is a fund management service provider. The company provides structuring, executing and managing investments within energy infrastructure. It invests in energy infrastructure assets including offshore wind, onshore wind, offshore power transmission, …
  • Kansas City Power & Light Co：発電所・企業SWOT分析
    Kansas City Power & Light Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Premiere Global Services, Inc.：企業の戦略的SWOT分析
    Premiere Global Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Oil India Ltd (OIL)：企業の財務・戦略的SWOT分析
    Oil India Ltd (OIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Imperial Dax Company, Inc：企業の戦略・SWOT・財務情報
    Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report Summary Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Tetherex Pharmaceuticals Corp：製薬・医療：M&Aディール及び事業提携情報
    Summary Tetherex Pharmaceuticals Corp (Tetherex Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops novel medicines for the treatment of inflammation, thrombosis and tumor metastasis. Its lead pipeline product candidate SelK2, a humanized monoclonal antibody targets a cell …
  • Crown Bioscience Inc (6554)：製薬・医療：M&Aディール及び事業提携情報
    Summary Crown Bioscience Inc (Crown Bioscience) is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, onc …
  • Leigh Creek Energy Ltd (LCK)：企業の財務・戦略的SWOT分析
    Leigh Creek Energy Ltd (LCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Frito-Lay North America, Inc.：企業の戦略・SWOT・財務情報
    Frito-Lay North America, Inc. - Strategy, SWOT and Corporate Finance Report Summary Frito-Lay North America, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Royal Orchid Hotels Ltd：企業の戦略・SWOT・財務分析
    Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • BenevolentAI Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary BenevolentAI Ltd (BenevolentAI) is an artificial intelligence company that focuses on developing and applying artificial intelligence (AI) to produce new medicines for the treatment of diseases with unmet medical needs. The company’s platform enables scientists to design and develop new trea …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆